Active	Status	Sponsor type	Region	Phase	Filter
8 Active 15 Inactive 23 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dulin, Michael F
SKyRoCKeT, NCT05770817: The Study	Recruiting	N/A	360	US	N/A: SKyRoCKeT is an observational study	University of North Carolina, Charlotte, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Healthy	09/26	03/27
Tudor-Locke, Catrine
SKyRoCKeT, NCT05770817: The Study	Recruiting	N/A	360	US	N/A: SKyRoCKeT is an observational study	University of North Carolina, Charlotte, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Healthy	09/26	03/27
Wikstrom, Erik A
NCT03663361: Addressing Neuromuscular Deficits for Improved Outcomes in Ankle Rehabilitation	Recruiting	N/A	150	US	SMART Intervention, Standard of Care Intervention	Phillip Gribble, United States Department of Defense	Ankle Sprains	12/25	12/25
Moore, Linda
NCT04494724: Clazakizumab vs. Placebo - COVID-19 Infection	Recruiting	2	60	US	Clazakizumab, Placebo	The Methodist Hospital System	COVID-19 Infection	12/20	07/21
Gunn, Laura H
SKyRoCKeT, NCT05770817: The Study	Recruiting	N/A	360	US	N/A: SKyRoCKeT is an observational study	University of North Carolina, Charlotte, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Healthy	09/26	03/27
Moore-Harrison, Trudy
SKyRoCKeT, NCT05770817: The Study	Recruiting	N/A	360	US	N/A: SKyRoCKeT is an observational study	University of North Carolina, Charlotte, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Healthy	09/26	03/27
Chen, Zhuo
NCT05901987: Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients	Recruiting	1/2	33	RoW	GC101	GeneCradle Inc	SMA II	05/25	12/28
Z-Flo, NCT06573034: Daoist Zhanzhuang and Human Flourishing	Recruiting	N/A	120	US	Daoist Zhanzhuang, Sham Wall Squat	University of North Carolina, Charlotte	Stress, Physiological, Stress, Psychological, Inflammatory Response, Well-Being, Psychological	02/27	07/27